Targeted Drug/Gene/Photodynamic Therapy via a Stimuli‐Responsive Dendritic‐Polymer‐Based Nanococktail for Treatment of EGFR‐TKI‐Resistant Non‐Small‐Cell Lung Cancer-Reference-Cited by-同舟云学术

Targeted Drug/Gene/Photodynamic Therapy via a Stimuli‐Responsive Dendritic‐Polymer‐Based Nanococktail for Treatment of EGFR‐TKI‐Resistant Non‐Small‐Cell Lung Cancer

Published:2022-05-31 Issue:27 Volume:34 Page:2201516
ISSN:0935-9648
Container-title:Advanced Materials
language:en
Short-container-title:Advanced Materials

Author:

Huang Jinxing¹,Zhuang Cheng¹,Chen Jie¹,Chen Xuanming¹,Li Xiaojie¹,Zhang Ting¹,Wang Bing¹,Feng Qiyi¹,Zheng Xiuli¹,Gong Meng¹²,Gong Qiyong¹³,Xiao Kai¹³^ORCID,Luo Kui¹³,Li Weimin¹³

Affiliation:

1. Precision Medicine Research Center Huaxi MR Research Center (HMRRC) Frontiers Science Center for Disease‐Related Molecular Network National Clinical Research Center for Geriatrics Department of Respiratory Medicine and Department of Radiology State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu 610041 China

2. West China‐Washington Mitochondria and Metabolism Research Center West China Hospital Sichuan University Chengdu 610041 China

3. Sichuan Provincial Key Laboratory of Precision Medicine Functional and Molecular Imaging Key Laboratory of Sichuan Province and Research Unit of Psychoradiology Chinese Academy of Medical Sciences Chengdu 610041 China

Funder

National Natural Science Foundation of China

West China Hospital, Sichuan University

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adma.202201516

Reference55 articles.

1. Hippo pathway effector YAP inhibition restores the sensitivity of EGFR-TKI in lung adenocarcinoma having primary or acquired EGFR-TKI resistance

2. A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components